Armistice Capital »

Yandex Nv-a shares owned by Armistice Capital

Quarter-by-quarter ownership of Yandex Nv-a (NBIS) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Yandex Nv-a

Tip: Access up to 7 years of quarterly data

All positions including Yandex Nv-a held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Yandex Nv-a by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $24M 213k 112.27
2024-12-31 $16M 561k 27.70

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Yandex Nv-a

Orbis Allan Gray
Susquehanna International
Citadel Advisors
Fred Alger Management
Jane Street
Wells Fargo & Company
Jericho Capital Asset Management
Accel Leaders 4 Associates
Altshuler Shaham
UBS Group
Millennium Management
Invesco
Two Sigma Investments
Two Sigma Advisers
Value Aligned Research Advisors

View all funds holding Yandex Nv-a